UiPath ultimately offers an Agentic automation platform that benefits from AI. However, stock markets are not convinced that ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Shares of UiPath Inc. (NYSE: PATH) have been on a tear, grabbing fresh attention after the company posted better-than-expected fiscal year 2026 (FY 2026) Q3 earnings and broke out to new 52-week highs ...

If you are wondering whether UiPath's current share price reflects its potential value or if it is already pricing in too much risk, this article will help you frame that question clearly. UiPath's ...

UiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

UiPath (PATH) concluded the recent trading session at $10.51, signifying a -1.77% move from its prior day's close.

“Together, we've turned the promise of agentic automation into a powerful reality,” UiPath CEO and founder Daniel Dines said. UiPath executives attributed part of the robotic process automation ...

UiPath (PATH) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.11 per share a year ago. These figures are ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

UiPath shares are down more than 5% after the automation-software company released improved earnings but forecast a slowdown in revenue growth for the fiscal year. Petco Health & Wellness shares are ...